Drug intelligence / Profile preview

glycol salicylate

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Glycol salicylate is a non-steroidal anti-inflammatory drug (NSAID) and a member of the salicylates, chemically known as 2-hydroxyethyl salicylate. It is formed by the condensation of the carboxy group of salicylic acid with one hydroxy group of ethylene glycol. Glycol salicylate is primarily used as an active ingredient in topical creams, sprays, and patches for the relief of mild to moderate muscle and joint pain, including aches, pains, stiffness, arthritis, sprains, or strains. Its mechanism involves inhibition of cyclooxygenase (COX) enzyme via its metabolite (salicylic acid), leading to decreased formation of pro-inflammatory prostaglandins[1][3][4][5]. The drug acts locally when applied topically and may also function as a counter-irritant by causing mild skin irritation that distracts from deeper musculoskeletal pain[8].

Other names
glycol salicylate2-hydroxyethyl salicylateethylene glycol monosalicylate2-hydroxyethyl 2-hydroxybenzoate
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on glycol salicylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycol salicylate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call